Looking Closely at the Growth Curve for Revolution Medicines Inc. (RVMD) – News Heater
Home  »  Business   »  Looking Closely at the Growth Curve for Revolution...

Looking Closely at the Growth Curve for Revolution Medicines Inc. (RVMD)

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Revolution Medicines Inc. (NASDAQ:RVMD) went up by 0.59% from its latest closing price compared to the recent 1-year high of $56.18. The company’s stock price has collected -6.84% of loss in the last five trading sessions. Press Release reported 17 hours ago that Revolution Medicines to Participate in 4th Annual Evercore ISI HealthCONx Conference

Is It Worth Investing in Revolution Medicines Inc. (NASDAQ :RVMD) Right Now?

Opinions of the stock are interesting as 4 analysts out of 7 who provided ratings for Revolution Medicines Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 3 rated it as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


The average price from analysts is $36.00, which is $7.13 above the current price. RVMD currently public float of 72.77M and currently shorts hold a 13.21% ratio of that float. Today, the average trading volume of RVMD was 454.01K shares.

RVMD’s Market Performance

RVMD stocks went down by -6.84% for the week, with a monthly jump of 6.41% and a quarterly performance of 5.29%, while its annual performance rate touched -30.75%. The volatility ratio for the week stands at 5.74% while the volatility levels for the past 30 days are set at 5.65% for Revolution Medicines Inc.. The simple moving average for the period of the last 20 days is -7.38% for RVMD stocks with a simple moving average of -15.09% for the last 200 days.

Analysts’ Opinion of RVMD

Many brokerage firms have already submitted their reports for RVMD stocks, with Stifel repeating the rating for RVMD by listing it as a “Hold.” The predicted price for RVMD in the upcoming period, according to Stifel is $34 based on the research report published on September 23rd of the current year 2021.

Goldman, on the other hand, stated in their research note that they expect to see RVMD reach a price target of $27, previously predicting the price at $49. The rating they have provided for RVMD stocks is “Neutral” according to the report published on August 12th, 2021.

Goldman gave a rating of “Buy” to RVMD, setting the target price at $49 in the report published on May 18th of the current year.

RVMD Trading at -2.77% from the 50-Day Moving Average

After a stumble in the market that brought RVMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -48.61% of loss for the given period.

Volatility was left at 5.65%, however, over the last 30 days, the volatility rate increased by 5.74%, as shares surge +4.64% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.72% lower at present.

During the last 5 trading sessions, RVMD fell by -6.84%, which changed the moving average for the period of 200-days by -45.09% in comparison to the 20-day moving average, which settled at $31.23. In addition, Revolution Medicines Inc. saw -27.08% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at RVMD starting from Anders Jack, who sale 166 shares at the price of $30.02 back on Sep 17. After this action, Anders Jack now owns 8,192 shares of Revolution Medicines Inc., valued at $4,983 using the latest closing price.

Wang Xiaolin, the See Remarks of Revolution Medicines Inc., sale 250 shares at $30.02 during a trade that took place back on Sep 17, which means that Wang Xiaolin is holding 12,195 shares at $7,505 based on the most recent closing price.

Stock Fundamentals for RVMD

Current profitability levels for the company are sitting at:

  • -257.54 for the present operating margin

The net margin for Revolution Medicines Inc. stands at -251.63. The total capital return value is set at -33.54, while invested capital returns managed to touch -32.97. Equity return is now at value -26.80, with -23.40 for asset returns.

Based on Revolution Medicines Inc. (RVMD), the company’s capital structure generated 6.89 points at debt to equity in total, while total debt to capital is 6.44. Total debt to assets is 5.57, with long-term debt to equity ratio resting at 6.11. Finally, the long-term debt to capital ratio is 5.71.

>> 7 Top Picks for the Post-Pandemic Economy <<

When we switch over and look at the enterprise to sales, we see a ratio of 59.51, with the company’s debt to enterprise value settled at 0.01. The receivables turnover for the company is 5.68 and the total asset turnover is 0.11. The liquidity ratio also appears to be rather interesting for investors as it stands at 9.63.

Sign up for our FREE Newsletter and get:

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:




Download Free eBook For


100% free. stop anytime no spam




Download Free eBook For


100% free. stop anytime no spam